Invokana is a new medication on the market whose primary target is type 2 diabetes. Invokana works in a clever way, helping to eliminate extra sugar from the body.
Current medications for type 2 diabetes are focused on insulin efficiency in the body or pancreas stimulation. This medication is not insulin focused. Invokana works by bypassing the usual plumbing that occurs in the body when it is processing extra sugar.
Invokana is an SGLT2 inhibitor. What does this mean for you in non-medical terminology? Simply put, this drug stops the kidneys from injecting sugar back into the bloodstream after they process it out. Instead of sugar re-entering the blood stream, it’s excreted through the urine. [Read more...]








